Showing 5151-5160 of 7368 results for "".
- Business News: Solta IPO Put on Icehttps://practicaldermatology.com/news/business-news-solta-ipo-put-on-ice/2461239/Bausch Health Companies Inc. is suspending its plans for the Solta IPO due to challenging market conditions and other factors. Bausch Health stated that the interests of the Company's stakeholders are best served in the near-term by focusing on driving Solta's revenue, profits a
- New Crystal Ball Predictions Released by Allergan Aestheticshttps://practicaldermatology.com/news/new-crystal-ball-predictions-released-by-allergan-aesthetics/2461238/Consumer interest in medical aesthetics continues to rise, with the number of dermal filler treatments worldwide growing by almost two million between 2017 and 2020, according to Allergan Aesthetics’ 'The Future of Aesthetics' global trends report. In addition, the r
- CeraVe and Dr. Amy Brodsky to Observe Sun Safety Day at Wrigley Fieldhttps://practicaldermatology.com/news/cerave-and-dr-amy-brodsky-to-observe-sun-safety-day-at-wrigley-field/2461235/CeraVe is sponsoring Sun Safety Day at Wrigley Field this weekend with event founder, Chicago-based board-certified dermatologist, Amy Brodsky, MD. Melanoma diagnosis in young adults is up 253% in the last 40 years. Sun damage in childhood is one of the leading factors o
- Nu Skin Kicks Off Its Global Day of Service with Projects for Childrenhttps://practicaldermatology.com/news/nu-skin-kicks-off-its-global-day-of-service-with-projects-for-children/2461233/Nu Skin is hosting its 19th annual Force for Good Day to support its global humanitarian efforts. To celebrate the company's founding and to give back to local communities, each Nu Skin region sets aside a day to participate in service projects as part of its mission to b
- Calling All Dermatologists: The Sun Heroes Initiative Wants You to Become a Herohttps://practicaldermatology.com/news/calling-all-dermatologists-the-sun-heroes-initiative-wants-you-to-help-bring-sun-safety-programs-to-elementary-schools/2461232/CeraVe and L'Oreal Dermatological Beauty brand La Roche-Posay are teaming up with dermatologist Amy Brodsky, MD to bring sun safety programs to elementary schools around the country. Sun Heroes is an educational program that equips healthcare professionals with
- FDA Approves Olumiant from Eli Lilly for Alopecia Areatahttps://practicaldermatology.com/news/fda-approves-olumiant-from-eli-lilly-for-alopecia-areata/2461231/Olumiant (baricitinib) from Eli Lilly and Company is approved to treat adult patients with severe alopecia areata. FDA action marks the first approval of a systemic treatment for alopecia areata. Olumiant is
- And the Winners Are...Newsweek Names America’s Top Dermatologistshttps://practicaldermatology.com/news/and-the-winners-arenewsweek-names-americas-top-dermatologists/2461226/Newsweek has released the 2022 America‘s Best Dermatologists List in partnership with Statista. The list is split into two categories: cosmetic and medical and includes 275 dermatologists (125 cosmetic and 150 medical), many of whom sit on Practical Dermatology® and sister pub
- Verrica Receives Complete Response Letter from FDA for NDA for VP-102https://practicaldermatology.com/news/verrica-receives-complete-response-letter-from-fda-for-nda-for-vp-102/2461214/The FDA has issued a Complete Response Letter (CRL) regarding Verrica Pharmaceuticals Inc.'s New Drug Application (NDA) for VP-102 for the treatment of molluscum contagiosum (molluscum). According to the company, the only deficiency listed in the CRL was related to the deficiencies
- Global Dermatology Coalition Launcheshttps://practicaldermatology.com/news/global-dermatology-coalition-launches/2461212/The Global Dermatology Coalition, a patient-led, multi-stakeholder group of organizations, has launched during the 75th World Health Assembly in Geneva. The Global D
- Amytrx Therapeutics Raises $18M for New AD Treatmenthttps://practicaldermatology.com/news/amytrx-therapeutics-raises-18m-for-new-ad-treatment/2461211/Amytrx Therapeutics closed on its final tranche of its Series A capital raise, totaling $18 million to expand on its clinical research investigating AMTX-100, a new cell- penetrating immune system modulating peptide therapeutic for topical skin applications, specifically in atopic derma